Anemia, a condition characterized by a deficiency of red blood cells or hemoglobin in the blood, can lead to fatigue and reduced quality of life.
It is often associated with various underlying health issues, including hypogonadism, a condition in which the body produces insufficient testosterone.
A recent study published in JAMA Network Open explores the potential of Testosterone Replacement Therapy (TRT) to correct anemia in middle-aged and older men with hypogonadism.
The study, led by Karol M. Pencina, Ph.D., from Brigham and Women’s Hospital in Boston, involved a placebo-controlled trial conducted at 316 U.S. sites.
The researchers enrolled 5,204 eligible men aged 45 to 80 years, all of whom presented with hypogonadal symptoms and either had cardiovascular disease or an increased risk of cardiovascular disease. Of this group, 815 had anemia, while 4,379 did not.
The study’s results were encouraging.
They showed that, compared to men who received a placebo, those treated with testosterone had a significantly higher percentage of corrected anemia at various time points: six months (41.0% versus 27.5%), 12 months (45.0% versus 33.9%), 24 months (42.8% versus 30.9%), 36 months (43.5% versus 33.2%), and 48 months (44.6% versus 39.2%).
Additionally, among participants without anemia at the beginning of the study, a smaller proportion of those receiving testosterone developed anemia compared to those in the placebo group.
The study also identified a connection between changes in hemoglobin levels and changes in energy levels among the participants.
Conclusion
This study suggests that Testosterone Replacement Therapy (TRT) may be an effective approach for correcting anemia in middle-aged and older men with hypogonadism.
Anemia can have a significant impact on an individual’s well-being, leading to symptoms like fatigue and reduced quality of life.
While further research and clinical trials may be needed to confirm and expand upon these findings, this study provides promising insights into a potential treatment option for individuals with anemia associated with hypogonadism.
Note: It’s important to mention that several authors of this study disclosed ties to the pharmaceutical industry, and one author reported holding a patent for a free testosterone calculator.
This information underscores the importance of transparency and potential conflicts of interest in medical research.
If you care about nutrition, please read studies about foods that could improve survival in Parkinson’s disease, and vitamin D supplements strongly reduce cancer death.
For more information about nutrition, please see recent studies about plant nutrient that could help reduce high blood pressure, and these antioxidants could help reduce dementia risk.
The research findings can be found in JAMA Network Open.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
